Gbs/cidp Foundation International
To provide support to those affected by Guillain-Barre syndrome
Based in PA
AI Overview
With $360K in lobbying spend across 36 quarterly filings, Gbs/cidp Foundation International is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $40K |
| 2019 | $40K |
| 2020 | $50K |
| 2021 | $40K |
| 2022 | $60K |
| 2023 | $60K |
| 2024 | $50K |
| 2025 | $20K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Gbs/cidp Foundation International disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations
Patient's Access to Treatments Act
GBS/CIDP research at NIH
FDA, Patient Focused Drug Development Initiative
Access to Marketplace Insurance Act
CIDP, MMN Home Infusion
Healthcare Reform, Pat
FY17 L-HHS Appropriations, Medical Research & Public Health
FY17 DoD Appropriations (Research Programs)
FY18 DoD/HHS Approps
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.